June 7th, 2021 - Biogen's (BIIB) FDA Approval

It's Monday, June 7th, 2021. I'm Hoda, Co-founder and CEO of Stock Card. This is what happened in the stock market today.

I reviewed how investors' sentiment held the market back for one more day and announced an exciting new feature on Stock Card. I also covered the major Alzheimer drug news that launched Biogen stock’s (#BIIB) and investigated a slight dip in UiPath stock’s (#PATH) price in advance of its first earnings report.

👉 Here's the list of companies reporting their earnings this week: https://stockcard.io/tools/earnings?u...

👉 If you haven't signed up for a free Stock Card account, don't forget to sign up today: https://stockcard.io/?utm_medium=YouT...

👉 By the way, neither I nor Stock Card, Inc. is a broker, a dealer, or a registered investment adviser, nor operated by either. Under no circumstances does any information posted on The Daily Market Recap or Stock Card's website and communications represent a recommendation to buy or sell a security. For more information, refer to our Terms of Use, Privacy Policy, and Disclosure Policy on the footer of our website: https://stockcard.io/